These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 7954419)
1. K252a, KT5720, KT5926, and U98017 support paclitaxel (taxol)-dependent cells and synergize with paclitaxel. Abraham I; Wolf CL; Sampson KE; Laborde AL; Shelly JA; Aristoff PA; Skulnick HI Cancer Res; 1994 Nov; 54(22):5889-94. PubMed ID: 7954419 [TBL] [Abstract][Full Text] [Related]
2. KT5720 and U-98017 inhibit MAPK and alter the cytoskeleton and cell morphology. Olsen MK; Reszka AA; Abraham I J Cell Physiol; 1998 Sep; 176(3):525-36. PubMed ID: 9699505 [TBL] [Abstract][Full Text] [Related]
3. Potent and preferential inhibition of Ca2+/calmodulin-dependent protein kinase II by K252a and its derivative, KT5926. Hashimoto Y; Nakayama T; Teramoto T; Kato H; Watanabe T; Kinoshita M; Tsukamoto K; Tokunaga K; Kurokawa K; Nakanishi S Biochem Biophys Res Commun; 1991 Nov; 181(1):423-9. PubMed ID: 1659814 [TBL] [Abstract][Full Text] [Related]
4. Studies on the antiviral mechanisms of protein kinase inhibitors K-252a and KT5926 against the replication of vesicular stomatitis virus. Kim YS; Kawai A Biol Pharm Bull; 1998 May; 21(5):498-505. PubMed ID: 9635507 [TBL] [Abstract][Full Text] [Related]
5. KT5926, a potent and selective inhibitor of myosin light chain kinase. Nakanishi S; Yamada K; Iwahashi K; Kuroda K; Kase H Mol Pharmacol; 1990 Apr; 37(4):482-8. PubMed ID: 2325635 [TBL] [Abstract][Full Text] [Related]
6. Multiple kinase arrest points in the G1 phase of nontransformed mammalian cells are absent in transformed cells. Gadbois DM; Crissman HA; Tobey RA; Bradbury EM Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8626-30. PubMed ID: 1528872 [TBL] [Abstract][Full Text] [Related]
7. Induction of differentiation of HL-60 cells by protein kinase C inhibitor, K252a. Taoka T; Tokuda M; Tasaka T; Hatase O; Irino S; Norman AW Biochem Biophys Res Commun; 1990 Aug; 170(3):1151-6. PubMed ID: 2390082 [TBL] [Abstract][Full Text] [Related]
8. Identification of a 170 kDa membrane kinase with increased activity in KB-V1 multidrug resistant cells. Sampson KE; McCroskey MC; Abraham I J Cell Biochem; 1993 Aug; 52(4):384-95. PubMed ID: 7693726 [TBL] [Abstract][Full Text] [Related]
9. The K252a derivatives, inhibitors for the PAK/MLK kinase family selectively block the growth of RAS transformants. Nheu TV; He H; Hirokawa Y; Tamaki K; Florin L; Schmitz ML; Suzuki-Takahashi I; Jorissen RN; Burgess AW; Nishimura S; Wood J; Maruta H Cancer J; 2002; 8(4):328-36. PubMed ID: 12184411 [TBL] [Abstract][Full Text] [Related]
10. Concentration-dependent stimulation and inhibition of growth cone behavior and neurite elongation by protein kinase inhibitors KT5926 and K-252a. Oberstar JV; Challacombe JF; Roche FK; Letourneau PC J Neurobiol; 1997 Aug; 33(2):161-71. PubMed ID: 9240372 [TBL] [Abstract][Full Text] [Related]
11. Studies on the antiviral activity of protein kinase inhibitors against the replication of vesicular stomatitis virus. Kim YS; Sagara J; Kawai A Biol Pharm Bull; 1995 Jun; 18(6):895-9. PubMed ID: 7550128 [TBL] [Abstract][Full Text] [Related]
12. Certain inhibitors of protein serine/threonine kinases also inhibit tyrosine phosphorylation of phospholipase C gamma 1 and other proteins and reveal distinct roles for tyrosine kinase(s) and protein kinase C in stimulated, rat basophilic RBL-2H3 cells. Yamada K; Jelsema CL; Beaven MA J Immunol; 1992 Aug; 149(3):1031-7. PubMed ID: 1378861 [TBL] [Abstract][Full Text] [Related]
13. Inhibitors of cGMP-dependent protein kinase block senescence induced by inactivation of T antigen in SV40-transformed immortal human fibroblasts. Fujii M; Ide T; Wadhwa R; Tahara H; Kaul SC; Mitsui Y; Ogata T; Oishi M; Ayusawa D Oncogene; 1995 Aug; 11(4):627-34. PubMed ID: 7651725 [TBL] [Abstract][Full Text] [Related]
14. The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis. Naumova E; Ubezio P; Garofalo A; Borsotti P; Cassis L; Riccardi E; Scanziani E; Eccles SA; Bani MR; Giavazzi R Clin Cancer Res; 2006 Mar; 12(6):1839-49. PubMed ID: 16551869 [TBL] [Abstract][Full Text] [Related]
15. K252a, a potent inhibitor of protein kinases, promotes the transition of Dictyostelium cells from growth to differentiation. Furukawa T; Maeda Y Zoolog Sci; 1994 Feb; 11(1):69-76. PubMed ID: 7765185 [TBL] [Abstract][Full Text] [Related]
16. Marine pyrrolocarbazoles and analogues: synthesis and kinase inhibition. Deslandes S; Chassaing S; Delfourne E Mar Drugs; 2009 Dec; 7(4):754-86. PubMed ID: 20098609 [TBL] [Abstract][Full Text] [Related]
17. Staurosporine, a novel protein kinase C inhibitor, prevents postischemic neuronal damage in the gerbil and rat. Hara H; Onodera H; Yoshidomi M; Matsuda Y; Kogure K J Cereb Blood Flow Metab; 1990 Sep; 10(5):646-53. PubMed ID: 2384538 [TBL] [Abstract][Full Text] [Related]
18. Hierarchical analysis of the nerve growth factor-dependent and nerve growth factor-independent differentiation signaling pathways in PC12 cells with protein kinase inhibitors. Campbell XZ; Neet KE J Neurosci Res; 1995 Oct; 42(2):207-19. PubMed ID: 8568921 [TBL] [Abstract][Full Text] [Related]
19. Effect of protein kinase inhibitors on activity of mammalian small heat-shock protein (HSP25) kinase. Hayess K; Benndorf R Biochem Pharmacol; 1997 May; 53(9):1239-47. PubMed ID: 9214684 [TBL] [Abstract][Full Text] [Related]
20. Anti-proliferative effect of the kinase inhibitor K252a on human prostatic carcinoma cell lines. Delsite R; Djakiew D J Androl; 1996; 17(5):481-90. PubMed ID: 8957691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]